Loading...
Found 6 Eye Disease trials
A listing of Eye Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
This study investigates the effectiveness of Selective Laser Trabeculoplasty (SLT) at low energy levels for individuals with ocular hypertension and glaucoma. The purpose of this study is to compare the outcomes of low-energy SLT with standard-energy SLT in maintaining eye health.The study focuses on assessing whether repeating low-energy SLT annually …
Increasing evidence points to the existence of a gut-eye axis, with alterations in the intestinal microbiome composition and its byproducts linked to a multitude of prevalent ocular diseases The purpose of this study is to describe the intestinal microbiome composition patients with a variety of ocular diseases by establishing a …
This study investigates X-linked retinoschisis (XLRS).The purpose of this study is to evaluate the safety and effectiveness of an investigational medication.Who can participate: Participants must be 6 years or older and have a clinical diagnosis of XLRS due to RS1 mutations. Both males and females with specific genetic criteria can …
The study is designed to evaluate the efficacy and safety of brenipatide verse placebo in adults with mild alcohol use disorder (AUD). This study will investigate the effects of brenipatide across a wide dose range to inform further clinical development of the molecule for the treatment of AUD.
Featured study
This study is a biorepository that collects and stores ocular fluid specimens obtained during routine ophthalmic procedures. The purpose of the biorepository is to support future research aimed at understanding ocular diseases, identifying biomarkers, and improving diagnostic or therapeutic approaches. No extra procedures are performed for research purposes: only small …
This study investigates the safety and effectiveness of two investigational medications in treating HER2-negative metastatic breast cancer. The study involves two investigational medications given in sequence, either trastuzumab deruxtecan followed by datopotamab deruxtecan or vice versa, to understand if this approach works for patients who have already tried other similar …
Please choose between Voice or SMS based delivery of verification code
or